FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
Maisa Yoshimoto(University of Alberta), Jeremy A. Squire(Universidade de São Paulo), Isabela Werneck da Cunha(AC Camargo Hospital), Renata A. Coudry(AC Camargo Hospital), Fernando Augusto Soares(University of Connecticut), César Torres(Universidade de São Paulo), F.P. Fonseca(AC Camargo Hospital)
Cited by 294
Related Papers
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
|Modern Pathology|2008|278
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
|Journal of Clinical Oncology|2011|256
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
|Modern Pathology|2021|254
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
|Modern Pathology|2021|222
<i>PTEN</i> genomic deletion is associated with p‐Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
|The Journal of Pathology|2009|210